glp 1 agonist addiction Is the next frontier for GLP-1 receptor agonists? GLP-1 agonists reduce substance use

In parallel, efforts are underway to identify early biomarkers, including those based on cerebrospinal fluid (CSF), peripheral blood, imaging modalities, and multi-omic signatures, to enable earlier intervention, before extensive neuronal loss has occurred

Animal research has also described accelerated repair of tendon, ligament, muscle, bone and gut tissue , alongside cytoprotective and anti-inflammatory activity particularly protection of the gastrointestinal lining [2] [4]

Whilst low levels can result in these conditions, there is also research available on using glutathione to improve outcomes in these patients

After 36 weeks of open-label tirzepatide treatment producing an average 20.9 percent weight loss, participants were randomized to either continue tirzepatide or switch to placebo